Aeolus Pharmaceuticals Inc AOLS
$0.00
Last Updated: Jul 29, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
Aeolus Pharmaceuticals Inc. Stock Analysis AOLS
United States Health Care Nano Cap Aeolus Pharmaceuticals, Inc. is a pharmaceutical company, which engages in developing a portfolio of novel metalloporphyrins. AEOL-10150 is catalytic antioxidant compound based on technology developed at Duke University and National Jewish Health. These compounds, known as metalloporphyrins, scavenge reactive oxygen species at the cellular level, mimicking the effect of the body’s own natural antioxidant enzyme superoxide dismutase. The Company’s products include AEOL 10150, AEOL 11207, and ED-Customer.com. The company also has two programs underway for the development of its second drug candidate, AEOL 11207, for the treatment of epilepsy and Parkinson’s disease. Its AEOL 10150 product includes catalytic antioxidant program, which is designed to retain the catalytic mechanism and high antioxidant efficiency of the natural enzymes and create and develop stable and small molecule antioxidants without the limitations of superoxide dismutase.
Aeolus Pharmaceuticals Inc (AOLS) Chart
Financial Metrics & Statements of Aeolus Pharmaceuticals Inc (AOLS)
FAQ's for Aeolus Pharmaceuticals Inc (AOLS)
- As of August 2026, Aeolus Pharmaceuticals Inc AOLS is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Aeolus Pharmaceuticals Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Aeolus Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Aeolus Pharmaceuticals Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Aeolus Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Aeolus Pharmaceuticals Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Aeolus Pharmaceuticals Inc (AOLS)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
